Feedback / Questions
PH-762 TME - Phio Pharma
https://phiopharma.com/phio-pharmaceuticals-announces-positive-safety-monitoring-committee-recommendation-to-advance-intasyl-ph-762-skin-cancer-clinical-trial-to-fifth-dose-escalation-cohort/
Jun 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next